Open AccessThe impact of pretransplant hepatic encephalopathy, model for end-stage liver disease (MELD) scale on long-term survival following deceased donor liver transplantation: a retrospective study
Author(s) -
Ji-Uk Yoon,
Yeong Min Yoo,
GyeongJo Byeon,
Hye-Jin Kim,
EunJi Choi,
Seyeon Park,
Hee Young Kim
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-21-21
Subject(s) - medicine , liver transplantation , hepatic encephalopathy , hazard ratio , retrospective cohort study , model for end stage liver disease , liver disease , incidence (geometry) , survival rate , transplantation , encephalopathy , gastroenterology , medical record , surgery , cirrhosis , confidence interval , physics , optics
Liver transplantation (LT) has the incidence of 30-day mortality about 5-10%, Jo et al. reported that 30-day mortality and 1-year mortality for DDLT were 30%, and 39% respectively. It is not easy to create a model for predicting post-transplantation outcomes based on pretransplant variables. MELD does not take into account individual complications such as hepatic encephalopathy (HE), and research has shown that the greater the severity of pretransplant HE, the lower the survival rate after LT; the importance of monitoring for HE is therefore emphasized.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom